BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac...
12th June, 2025
By Ludwig Burger (Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac...
12th June, 2025
(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 bi...
2nd June, 2025
(Reuters) -Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotec...
22nd May, 2025

ZURICH (Reuters) - Swiss biotech BioVersys, which develops treatments for serious infections caused...
6th February, 2025

STOCKHOLM (Reuters) – Danish biotech Bavarian Nordic said on Friday the order book for delivery of i...
16th November, 2024

By Patrick Wingrove (Reuters) -Novavax cut its annual revenue forecast on Tuesday, citing lower-than...
12th November, 2024

Finding the next big impact investing opportunity in the UK biotech sector By Alexandra Martinez, Co...
15th May, 2023

By Natalie Grover LONDON (Reuters) – Britain’s budget has offered a shot in the arm to research-inte...
16th March, 2023

(Reuters) – Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manuf...
19th August, 2022

By Amruta Khandekar and Leroy Leo (Reuters) – Plunging valuations have made biotech companies tempti...
12th August, 2022

New York, United States : DECISIVE MARKETS INSIGHTS has recently released a new industry research re...
16th September, 2021

Drug intermediates are the drugs used as raw materials for the production of bulk drugs, or they can...
5th August, 2021